Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2009-04-07
- Lead Sponsor
- British Columbia Cancer Agency
- Registration Number
- NCT00070083
- Locations
- 🇨🇦
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇺🇸Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- British Columbia Cancer Agency
- Registration Number
- NCT00061997
- Locations
- 🇨🇦
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
© Copyright 2024. All Rights Reserved by MedPath